TD Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-106,080
| Closed | -$321K | – | 1281 |
|
|
2024
Q4 | $321K | Hold |
106,080
| – | – | ﹤0.01% | 1206 |
|
|
2024
Q3 | $398K | Buy |
106,080
+3,200
| +3% | +$12K | ﹤0.01% | 1324 |
|
|
2024
Q2 | $421K | Sell |
102,880
-155,938
| -60% | -$638K | ﹤0.01% | 1295 |
|
|
2024
Q1 | $4.08M | Buy |
258,818
+68,650
| +36% | +$1.08M | ﹤0.01% | 819 |
|
|
2023
Q4 | $2.88M | Buy |
190,168
+9,400
| +5% | +$142K | ﹤0.01% | 890 |
|
|
2023
Q3 | $3.63M | Buy |
180,768
+78,140
| +76% | +$1.57M | ﹤0.01% | 801 |
|
|
2023
Q2 | $2.9M | Buy |
102,628
+19,921
| +24% | +$562K | ﹤0.01% | 863 |
|
|
2023
Q1 | $1.42M | Hold |
82,707
| – | – | ﹤0.01% | 1070 |
|
|
2022
Q4 | $1.67M | Hold |
82,707
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q3 | $1.78M | Buy |
82,707
+100
| +0.1% | +$2.15K | ﹤0.01% | 1039 |
|
|
2022
Q2 | $2.32M | Sell |
82,607
-23,296
| -22% | -$655K | ﹤0.01% | 967 |
|
|
2022
Q1 | $4.89M | Sell |
105,903
-11,730
| -10% | -$541K | ﹤0.01% | 830 |
|
|
2021
Q4 | $9.89M | Buy |
117,633
+26,375
| +29% | +$2.22M | 0.01% | 684 |
|
|
2021
Q3 | $6.08M | Buy |
91,258
+9,292
| +11% | +$619K | 0.01% | 776 |
|
|
2021
Q2 | $4.36M | Buy |
81,966
+52,751
| +181% | +$2.81M | ﹤0.01% | 864 |
|
|
2021
Q1 | $1.27M | Buy |
29,215
+4,722
| +19% | +$205K | ﹤0.01% | 1219 |
|
|
2020
Q4 | $1.27M | Buy |
24,493
+2,000
| +9% | +$104K | ﹤0.01% | 1125 |
|
|
2020
Q3 | $735K | Hold |
22,493
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q2 | $1.08M | Buy |
+22,493
| New | +$1.08M | ﹤0.01% | 1041 |
|